Puslecki Mateusz, Baumgart Konrad, Ligowski Marcin, Dabrowski Marek, Stefaniak Sebastian, Ladzinska Malgorzata, Goszczynska Ewa, Marcinkowski Pawel, Olasinska-Wisniewska Anna, Klosiewicz Tomasz, Pawlak Aleksander, Zielinski Marcin, Puslecki Lukasz, Podlewski Roland, Szarpak Lukasz, Jemielity Marek, Perek Bartlomiej
Department of Medical Rescue, Poznan University of Medical Sciences, Collegium Adama Wrzoska Rokietnicka Street 7, Poznan 60-806, Poland.
Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Dluga Street 1/2, Poznan 61-848, Poland.
Emerg Med Int. 2021 Feb 22;2021:6633208. doi: 10.1155/2021/6633208. eCollection 2021.
Extracorporeal membrane oxygenation (ECMO) has been proven to support in lifesaving rescue therapy. The best outcomes can be achieved in high-volume ECMO centers with dedicated emergency transport teams.
The aim of this study was to analyze the safety of ECMO support during medical transfer on the basis of our experience developed on innovation cooperation and review of literature.
A retrospective analysis of our experience of all ECMO-supported patients transferred from regional hospital of the referential ECMO center between 2015 and 2020 was carried out. Special attention was paid to transportation-related mortality and morbidity. Moreover, a systematic review of the Medline, Embase, Cochrane, and Google Scholar databases was performed. It included the original papers published before the end of 2019.
Twelve (5 women and 7 men) critically ill ECMO-supported patients with the median age of 33 years (2-63 years) were transferred to our ECMO center. In 92% ( = 11) of the cases venovenous and in 1 case, venoarterial supports were applied. The median transfer length was 45 km (5-200). There was no mortality during transfer and no serious adverse events occurred. Of note, the first ECMO-supported transfer had been proceeded by high-fidelity simulations. For our systematic review, 68 articles were found and 22 of them satisfied the search criteria. A total number of 2647 transfers were reported, mainly primary (90%) and as ground transportations (91.6%). A rate of adverse events ranged from 1% through 20% but notably only major complications were mentioned. The 4 deaths occurred during transport (mortality 0.15%).
Our experiences and literature review showed that transportation for ECMO patients done by experienced staff was associated with low mortality rate but life-threatening adverse events might occur. Translational simulation is an excellent probing technique to improve transportation safety.
体外膜肺氧合(ECMO)已被证明可用于挽救生命的救援治疗。在拥有专业紧急运输团队的大容量ECMO中心可取得最佳治疗效果。
本研究旨在根据我们在创新合作方面积累的经验以及文献综述,分析医疗转运期间ECMO支持的安全性。
对2015年至2020年间从参考ECMO中心的地区医院转出的所有接受ECMO支持患者的经验进行回顾性分析。特别关注与转运相关的死亡率和发病率。此外,还对Medline、Embase、Cochrane和谷歌学术数据库进行了系统综述。纳入2019年底之前发表的原始论文。
12例(5名女性和7名男性)接受ECMO支持的重症患者被转至我们的ECMO中心,中位年龄为33岁(2 - 63岁)。92%(n = 11)的病例采用静脉 - 静脉模式,1例采用静脉 - 动脉模式。中位转运距离为45公里(5 - 200公里)。转运期间无死亡病例,也未发生严重不良事件。值得注意的是,首次ECMO支持下的转运之前进行了高保真模拟。在我们的系统综述中,共找到68篇文章,其中22篇符合检索标准。共报告了2647例转运,主要为初次转运(90%)且多为地面运输(91.6%)。不良事件发生率在1%至20%之间,但仅提及了严重并发症。4例患者在转运期间死亡(死亡率0.15%)。
我们的经验和文献综述表明,由经验丰富的人员对ECMO患者进行转运,死亡率较低,但可能会发生危及生命的不良事件。模拟转换是提高转运安全性的一项出色探测技术。